Exelixis
Wendy Yang serves as the Director of Biologics CMC Program Management at Exelixis since June 2023, where responsibilities include leading the Biologics CMC program management team and overseeing project plans across various development stages. Prior to this role, Wendy held the position of Associate Director of Tech Ops, CMC Program Management at Pionyr Immunotherapeutics Inc, contributing to strategy and cross-functional collaborations, successfully managing substantial CMC projects, and expanding clinical supply sites. Wendy's background also includes significant roles at BioMarin Pharmaceutical Inc. and Sanofi, where strategic project management, portfolio alignment, and outsourcing activities were key focuses. Wendy holds an MBA from Babson F.W. Olin Graduate School of Business and a Master’s degree in Biology from the University of Alberta, complemented by a Project Management Professional Certificate.
This person is not in any teams
Exelixis
15 followers
Exelixis strives to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future.